Hidetada Ogata

502 total citations
22 papers, 410 citations indexed

About

Hidetada Ogata is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Pharmaceutical Science. According to data from OpenAlex, Hidetada Ogata has authored 22 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pharmaceutical Science. Recurrent topics in Hidetada Ogata's work include Pancreatic function and diabetes (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Diabetes Treatment and Management (6 papers). Hidetada Ogata is often cited by papers focused on Pancreatic function and diabetes (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Diabetes Treatment and Management (6 papers). Hidetada Ogata collaborates with scholars based in Japan and United States. Hidetada Ogata's co-authors include Yusuke Seino, Yoji Hamada, Yutaka Oiso, Shin Tsunekawa, Atsushi Iida, Yoshitaka Hayashi, Nahoko Kaniwa, Akira Ejima, Kota Ishikawa and Nobuya Inagaki and has published in prestigious journals such as PLoS ONE, Diabetologia and International Journal of Pharmaceutics.

In The Last Decade

Hidetada Ogata

22 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetada Ogata Japan 13 157 140 131 85 51 22 410
Haruhisa Yamashita Japan 14 122 0.8× 82 0.6× 170 1.3× 120 1.4× 36 0.7× 29 631
Lynetta J. Jobe United States 6 134 0.9× 97 0.7× 127 1.0× 60 0.7× 29 0.6× 7 355
A M Coudray France 10 175 1.1× 116 0.8× 141 1.1× 67 0.8× 21 0.4× 13 438
Thora Bödvarsdóttir Denmark 14 202 1.3× 225 1.6× 209 1.6× 94 1.1× 57 1.1× 20 532
Marina Roques France 9 80 0.5× 94 0.7× 357 2.7× 241 2.8× 20 0.4× 10 518
Damien Demozay United States 6 174 1.1× 315 2.3× 216 1.6× 108 1.3× 203 4.0× 8 551
Hana E. Baker United States 11 233 1.5× 163 1.2× 163 1.2× 65 0.8× 18 0.4× 22 462
R. Fanska United States 15 329 2.1× 422 3.0× 259 2.0× 71 0.8× 169 3.3× 19 714
Joan Helmering United States 9 139 0.9× 88 0.6× 342 2.6× 178 2.1× 30 0.6× 11 581
Yasuhiro Sako Japan 12 339 2.2× 414 3.0× 285 2.2× 186 2.2× 194 3.8× 23 758

Countries citing papers authored by Hidetada Ogata

Since Specialization
Citations

This map shows the geographic impact of Hidetada Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetada Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetada Ogata more than expected).

Fields of papers citing papers by Hidetada Ogata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetada Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetada Ogata. The network helps show where Hidetada Ogata may publish in the future.

Co-authorship network of co-authors of Hidetada Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetada Ogata. A scholar is included among the top collaborators of Hidetada Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetada Ogata. Hidetada Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katahira, Masahito, Hidetada Ogata, Takahiro Ito, et al.. (2020). Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves’ disease and Hashimoto’s thyroiditis in the Japanese population. Human Immunology. 82(4). 226–231. 9 indexed citations
2.
3.
Ogata, Hidetada, Norio Harada, Kazuyo Suzuki, et al.. (2018). Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain. American Journal of Physiology-Endocrinology and Metabolism. 314(6). E572–E583. 18 indexed citations
4.
Seino, Yusuke, Hidetada Ogata, Atsushi Iida, et al.. (2017). Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice. The Journal of Nutritional Biochemistry. 49. 71–79. 45 indexed citations
5.
Iida, Atsushi, Yusuke Seino, Ayako Fukami, et al.. (2016). Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin. Diabetologia. 59(7). 1533–1541. 21 indexed citations
6.
Seino, Yusuke, et al.. (2016). Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1. Journal of Diabetes Investigation. 7(S1). 27–32. 24 indexed citations
7.
Katahira, Masahito & Hidetada Ogata. (2016). Thyroglobulin Autoantibodies Are Associated with Refractoriness to Antithyroid Drug Treatment for Graves' Disease. Internal Medicine. 55(12). 1519–1524. 7 indexed citations
8.
Ishikawa, Kota, Shin Tsunekawa, Atsushi Iida, et al.. (2015). Long-Term Pancreatic Beta Cell Exposure to High Levels of Glucose but Not Palmitate Induces DNA Methylation within the Insulin Gene Promoter and Represses Transcriptional Activity. PLoS ONE. 10(2). e0115350–e0115350. 48 indexed citations
9.
Seino, Yusuke, Hidetada Ogata, Atsushi Iida, et al.. (2015). Fructose induces glucose‐dependent insulinotropic polypeptide, glucagon‐like peptide‐1 and insulin secretion: Role of adenosine triphosphate‐sensitive K+ channels. Journal of Diabetes Investigation. 6(5). 522–526. 22 indexed citations
10.
Ogata, Hidetada, Yusuke Seino, Norio Harada, et al.. (2014). KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state. Journal of Endocrinology. 222(2). 191–200. 38 indexed citations
11.
Seino, Yusuke, Ayako Fukami, Shin Tsunekawa, et al.. (2012). Ingestion of a moderate high‐sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon‐like peptide‐1 secretion. Journal of Diabetes Investigation. 3(5). 432–440. 42 indexed citations
12.
Hanada, K., et al.. (2001). Sex-related differences in the renal disposition of the acidic metabolite of clentiazem in rat. Xenobiotica. 31(10). 725–731. 4 indexed citations
13.
Ogata, Hidetada, et al.. (1986). Effect of food on bioavailability of metronidazole from sugar-coated tablets having different dissolution rates in subjects with low gastric acidity.. PubMed. 24(6). 279–82. 10 indexed citations
14.
Ogata, Hidetada, et al.. (1985). BIavailability of metronidazole from sugar-coated tablets in humans. I. Effect of gastric acidity and correlation with in vitro dissolution rate. International Journal of Pharmaceutics. 23(3). 277–288. 15 indexed citations
15.
Ogata, Hidetada, et al.. (1985). Bioavailability of metronidazole from sugar-coated tablets in humans. II. Evaluation of beagle dogs as an animal model. International Journal of Pharmaceutics. 23(3). 289–298. 10 indexed citations
16.
Ogata, Hidetada, et al.. (1985). Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.. PubMed. 23(9). 469–74. 12 indexed citations
17.
Ogata, Hidetada, et al.. (1984). Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.. PubMed. 22(5). 240–5. 7 indexed citations
18.
Kaniwa, Nahoko, et al.. (1983). The bioavailability of flufenamic acid and its dissolution rate from capsules.. PubMed. 21(2). 56–63. 13 indexed citations
19.
Ogata, Hidetada, et al.. (1982). The bioavailability of diazepam from uncoated tablets in humans--Part II: effect of gastric fluid acidity.. PubMed. 20(4). 166–70. 17 indexed citations
20.
Ogata, Hidetada, et al.. (1982). The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.. PubMed. 20(4). 159–65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruhisa Yamashita Breakdown of academic impact, for papers by Lynetta J. Jobe Breakdown of academic impact, for papers by A M Coudray Breakdown of academic impact, for papers by Thora Bödvarsdóttir Breakdown of academic impact, for papers by Marina Roques Breakdown of academic impact, for papers by Damien Demozay Breakdown of academic impact, for papers by Hana E. Baker Breakdown of academic impact, for papers by R. Fanska Breakdown of academic impact, for papers by Joan Helmering Breakdown of academic impact, for papers by Yasuhiro Sako
Rankless by CCL
2026